Formoflo-G MDI combines three established therapies in a twice-daily inhaler after DCGI approval, targeting India’s large COPD patient pool
The post Lupin launches fixed-dose triple-combination inhaler for COPD in India appeared first on Home Page.
Formoflo-G MDI combines three established therapies in a twice-daily inhaler after DCGI approval, targeting India’s large COPD patient pool
The post Lupin launches fixed-dose triple-combination inhaler for COPD in India appeared first on Home Page.